Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE® to Provide Two Distinct and Complementary Perspectives.
Patient Relat Outcome Meas
; 13: 249-258, 2022.
Article
in En
| MEDLINE
| ID: mdl-36524232
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Language:
En
Journal:
Patient Relat Outcome Meas
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: